Anmeldung erfolgt in Kürze...
Details werden geladen...
Novo Nordisk pushes for staged PBS rollout for Ozempic and Wegovy to tackle Australia’s obesity crisis
Novo Nordisk, which also makes Wegovy, is maintaining pressure on the government for a PBS listing, arguing obesity is costing the economy $40 billion a year.